In summary, they observed that the activation of Nrf2 by sulforaphane inhibited high glucose-induced progression of pancreatic cancer via AMPK-dependent signaling, by the inhibition of clone formation, the migration of pancreatic cancer, and the promotion of apoptosis. The gene discussed is NFE2L2; the disease is familial pancreatic carcinoma.